This webinar, hosted on 27 October by IAS – the International AIDS Society – showcased the upcoming launch of the supplement through presentations of the latest science and lessons learned on differentiated service delivery (DSD) for HIV during COVID-19. Presentations highlighted the modifications made by HIV programmes in response to COVID-19 that should be maintained as part of a better structured service delivery system. In addition, the discussions focused on sub-Saharan Africa and remaining evidence gaps that could be addressed through future implementation research.


Supporting PrEP access for female sex workers in Zimbabwe during COVID-19 lockdown with community-based delivery, extended PrEP refills and virtual support during COVID-19 lockdown: Primrose Matambanadzo, Centre for Sexual Health and HIV/AIDS Research, Zimbabwe


Changes in utilization of DSD for HIV treatment during COVID-19 in Zambia: Youngji Jo, Boston Medical Centre, USA and Bevis Phiri, Clinton Health Access Initiative, Zambia

DSD for people on second-line antiretroviral therapy: Evidence from KwaZulu-Natal, South Africa: Jienchi Dorward, Centre for the AIDS Programme of Research in South Africa, South Africa

Earlier referral to a community-based DSD for HIV treatment model with multi-month dispensing and annual clinic visits: Data from two cluster-randomized trials in Lesotho and Zimbabwe: Trish Muzenda, Kheth’Impilo AIDS Free Living and School of Public Health and Family Medicine, University of Cape Town, South Africa

Silver linings: How COVID-19 expedited differentiated service delivery for HIV: Peter Ehrenkranz, Bill & Melinda Gates Foundation, USA


Anna Grimsrud, IAS – International AIDS Society, South Africa and Izukanji Sikazwe, Centre for Infectious Disease Research in Zambia, Zambia


Nelson Otwoma, National Empowerment Network of People living with HIV/AIDS in Kenya, Kenya


For any inquiries about these sessions, please contact us at [email protected]